Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.20%
SPX
-0.64%
IXIC
-1.15%
FTSE
-0.32%
N225
-0.26%
AXJO
-0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
31.73M
Dividend Yield
0.00%
P/E Ratio
-1.91
EPS
-1.46
Revenue
515.00K
Avg. Volume
32.14K

Recently from Cashu

publisher logo
Cashu

CollPlant Biotechnologies Showcases rhCollagen Innovations at H.C. Wainwright Conference 2025

2 days ago
publisher logo
Cashu

CollPlant Biotechnologies to Showcase Regenerative Medicine Innovations at H.C. Wainwright Conference

3 days ago
publisher logo
Cashu

Please provide the text you would like me to summarize into a title.

7 days ago

About

What does CLGN do?
CollPlant Biotechnologies specializes in regenerative and aesthetic medicine, offering products for tissue regeneration and organ production. Their technology relies on plant-based production of collagen type I (rhCollagen).
Sector
💻 Health Care
IPO
CEO
Employees
57
Headquarters
Israel
Website
http://www.collplant.com
Stocks
Health Care
clgn
CollPlant Biotechnologies New
NASDAQ: CLGN
-0.08 (-2.89%)
2.69
USD
At close at Aug 29, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials